Preclinical coronavirus studies and pathology: Challenges of the high-containment laboratory

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Baxter, V.K.
    • Affiliation: University of North Carolina at Chapel Hill
  • Montgomery, S.A.
    • Affiliation: University of North Carolina at Chapel Hill
Abstract
  • The COVID-19 pandemic has highlighted the critical role that animal models play in elucidating the pathogenesis of emerging diseases and rapidly analyzing potential medical countermeasures. Relevant pathologic outcomes are paramount in evaluating preclinical models and therapeutic outcomes and require careful advance planning. While there are numerous guidelines for attaining high-quality pathology specimens in routine animal studies, preclinical studies using coronaviruses are often conducted under biosafety level-3 (BSL3) conditions, which pose unique challenges and technical limitations. In such settings, rather than foregoing pathologic outcomes because of the inherent constraints of high-containment laboratory protocols, modifications can be made to conventional best practices of specimen collection. Particularly for those unfamiliar with working in a high-containment laboratory, the authors describe the logistics of conducting such work, focusing on animal experiments in BSL3 conditions. To promote scientific rigor and reproducibility and maximize the value of animal use, the authors provide specific points to be considered before, during, and following a high-containment animal study. The authors provide procedural modifications for attaining good quality pathologic assessment of the mouse lung, central nervous system, and blood specimens under high-containment conditions while being conscientious to maximize animal use for other concurrent assays.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
License
  • Attribution 4.0 International
Journal title
  • Veterinary Pathology
Journal volume
  • 59
Journal issue
  • 4
Page start
  • 556
Page end
  • 564
Language
  • English
Version
  • Publisher
Funder
  • National Institutes of Health, NIH: K01OD026529; National Cancer Institute, NCI: 5P30CA016086-41; University of North Carolina, UNC
ISSN
  • 0300-9858
Publisher
  • SAGE Publications Ltd

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details 03009858221087634.pdf 2023-01-12 Public Download